Skip to main content

Contractor intelligence · computed from public award records

PHARCO

Awards won
108
Known value
USD 7.0M
First award
11 Nov 2018
Most recent
22 Jul 2019

Wins by funder

FunderAwardsKnown valueMost recent
World Bank108USD 7.0M22 Jul 2019

Where the work is

EG · 108

Sources

The most recent award records behind the figures above. Every number on this page is computed from records like these — nothing is estimated or editorial.

  • all technical offers are acceptable for Ribavirin drugs · 25 Dec 2018 · USD 5K · World Bank
  • all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 12 Dec 2018 · USD 97K · World Bank
  • all technical offers are acceptable for Ribavirin drugs · 19 Nov 2018 · USD 3K · World Bank
  • all technical offers are acceptable for Ribavirin drugs · 19 Nov 2018 · USD 3K · World Bank
  • all technical offers are acceptable for Ribavirin drugs · 15 Nov 2018 · USD 3K · World Bank
  • all technical offers are acceptable for Ribavirin drugs · 13 Nov 2018 · USD 3K · World Bank
  • all technical offers are acceptable The Ribavirin drugs · 12 Nov 2018 · USD 3K · World Bank
  • all technical offers are accepted for The Sofosbuvir 400mg , Daclatasvir 60 mg drugs · 12 Nov 2018 · USD 95K · World Bank
  • all technical offers are acceptable The Ribavirin drugs · 12 Nov 2018 · USD 3K · World Bank
  • all technical offers are acceptable for Ribavirin drugs · 12 Nov 2018 · USD 3K · World Bank
  • all technical offers are acceptable The Ribavirin drugs · 12 Nov 2018 · USD 3K · World Bank
  • all technical offers are accepted for The Ribavirin drugs · 12 Nov 2018 · USD 3K · World Bank
  • all technical offers are accepted for The Ribavirin drugs · 12 Nov 2018 · USD 3K · World Bank
  • all technical offers are acceptable for Ribavirin drugs · 12 Nov 2018 · USD 3K · World Bank
  • all technical offers are accepted for The Ribavirin drugs · 12 Nov 2018 · USD 3K · World Bank
  • all technical offers are accepted for The Ribavirin drugs · 12 Nov 2018 · USD 3K · World Bank
  • all technical offers are accepted for the Ribavirin drugs · 12 Nov 2018 · USD 3K · World Bank
  • all technical offers are accepted for The Ribavirin drugs · 12 Nov 2018 · USD 3K · World Bank
  • all technical offers are accepted for The Sofosbuvir 400mg , Daclatasvir 60 mg drugs · 12 Nov 2018 · USD 96K · World Bank
  • all technical offers are acceptable The Ribavirin drugs · 12 Nov 2018 · USD 3K · World Bank

Method

Computed from 108 award records ingested from official disclosure sources (World Bank, Inter-American Development Bank, and published contract-award notices). Values are shown in USD where the source published one; entity identity is resolved conservatively and reviewed. GLODA is not affiliated with any funder or contractor shown. Last computed 15 Sept 2026.